Breast Cancer Clinical Trial
Official title:
A Holistic Medical Approach - The Effect of "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" on Breast Cancer Patients Undergoing Cancer Therapy
The goal of this study is to evaluate the impact of the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" on patients with breast cancer who are currently undergoing conventional Western medical treatments in Taiwan. The main questions it aims to answer are: Can the "Traditional Chinese Medicine Therapy Program" alleviate symptoms experienced by breast cancer patients? Does the program improve the quality of life for breast cancer patients receiving Western medical treatments? How does the program contribute to the management of side effects associated with Western oncological therapies? Participants will: Engage in the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" provided by the Taiwan Compassionate Cancer Care Association. Receive supportive and educational services, including auxiliary Chinese medicine treatment courses, lifestyle and health education, and psychological counseling. This study seeks to integrate the concept of holistic healthcare, emphasizing coordinated care that encompasses physical, mental, and social aspects, into the treatment of breast cancer.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | February 28, 2025 |
Est. primary completion date | February 28, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: - Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study. - Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine. - Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy. Exclusion Criteria: - Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine. - Patients regularly receiving Astragalus polysaccharide injections. - Patients with a history of allergies to Traditional Chinese Medicine. - Pregnant or breastfeeding women. - Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs. - Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form). |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei City Hospital | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei City Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Questionnaire: Constitution in Chinese Medicine Questionnaire | Observation and analysis Traditional Chinese Medicine Constitutions in breast cancer undergoing treatment | Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks | |
Primary | Questionnaire: Functional Assessment of Cancer Therapy-General Scale, FACT-G)(Version 4) | Observation and analysis to measure four domains of QoL in cancer patients: Physical, social, emotional, and functional well-being | Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks | |
Primary | Questionnaire: European Organisation for Research and Treatment of Cancer, EORTC QLQ-BR23) | Observation and analysis for measuring the quality of life in patients with breast cancer | Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks | |
Secondary | Additional questions regarding the "Traditional Chinese Medicine Program for Reinforcing Vital Energy" | Understanding and Course satisfaction and Confidence in cancer recovery | Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |